email   Email Us: phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2641-1687

Journal of Urology & Nephrology Studies

Review Article(ISSN: 2641-1687)

The Clinical Impact of Hexylaminolevulinate-Blue Light Cystoscopy on Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence and Progression: A Critical Review

Volume 1 - Issue 4

Omer Abdalla1,2,3*, Seshadri Sriprasad1,2 and Sanjeev Madaan1,2

  • Author Information Open or Close
    • 1Dartford and Gravesham NHS Foundation Trust
    • 2Canterbury Christ Church University
    • 3Portsmouth Hospitals NHS Foundation Trust

    *Corresponding author: Omer Abdalla, Dartford and Gravesham NHS Foundation Trust, Canterbury Christ Church University, Portsmouth Hospitals NHS Foundation Trust, UK

Received: May 14, 2019;   Published: May 22, 2019

DOI: 10.32474/JUNS.2019.01.000123

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF


The superficial bladder cancer is associated with high risk of recurrence and progression, necessitating lengthy follow up and repeated endoscopic treatments. White light cystoscopy (WLC) is the current gold standard for the diagnosis, treatment and surveillance, however the sensitivity and specificity isn’t perfect with risk of missing some tumours. A photodynamic diagnosis (PDD) using Blue-light cystoscopy is a novel concept proposed to overcome the WLC shortcomings. This critical review synthesizes the evidences on the effectiveness of Blue light cystoscopy (BLC) for the diagnosis of non-muscle invasive bladder cancer (NMIBC), and the impact of photodynamic diagnosis on the recurrence rate and progression of superficial bladder cancer..

Abstract| Introduction| Methodology| Conclusion| References|